Product Information
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $1.2133 per GM under NDC 00713084892. Its NADAC has been published 88 times since Aug 21, 2024.
FDA first approved this application on May 11, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION
calcipotriene and betamethasone dipropionateStrength
.5; 50 mg/g; ug/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713084892
Classification
Generic
Dosage Form
SUSPENSION
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEApproval Type
Generic (ANDA)
FDA Application
ANDA210765FDA Approved
5/11/2020
TE Code
AB
On Market Since
8/2/2024
Pharmacological Classes
Price Statistics
The NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has been published 88 times since Aug 21, 2024, and over the history we have for it it has declined 72.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2133 per GM |
|---|---|
| All-time high | $4.4529 (May 14, 2025) |
| All-time low | $0.8269 (Sep 17, 2025) |
| 52-week high | $1.2133 |
| 52-week low | $0.8269 |
| Median price | $1.2133 |
| Average price | $2.4919 |
| Largest weekly change | -81.4% (Sep 17, 2025) |
| Weeks tracked | 88 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, manufactured by Cosette Pharmaceuticals, Inc., is $1.2133 per GM (NDC 00713084892), effective Aug 19, 2026.
How has the price of CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION changed over time?
Over the history we have for it, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has declined 72.8%. It has been tracked across 88 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
Since Aug 21, 2024, the NADAC for CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION has ranged from a low of $0.8269 (Sep 17, 2025) to a high of $4.4529 (May 14, 2025), with a median of $1.2133 per GM.
Are there cheaper alternatives to CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION?
CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION (NDC 00713084892) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.